Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

osite, Inc. and Cholestech Corp. during

the second and third quarters of 2007, respectively.

(f) Purchase of in-process research and development during the nine

months ended September 30, 2007 includes a write-off of $169.0

million associated with the value of in-process research and

development costs incurred in connection with our acquisition of

Biosite, Inc.

(g) Charges totaling $15.6 million associated with the write-off of debt

origination costs and a prepayment premium paid upon early

extinguishment of related debt during the nine months ended

September 30, 2007, in conjunction with our financing arrangements.

(h) A $1.7 million net realized foreign currency loss associated with a

cash escrow established in connection with the acquisition of BBI

Holdings Plc.

(i) A $1.9 million foreign currency gain realized on the settlement of

intercompany notes.

(j) Tax effect on adjustments as discussed above in notes (b), ( c ),

(d), (e), (f), (g), (h) and (i).

(k) For the nine months ended September 30, 2008 and 2007, potential

dilutive shares were not used in the calculation of diluted net loss

per common share under GAAP because inclusion thereof would be

antidilutive.

(l) Included in the weighted average diluted common shares for the

calculation of net income per common share for the nine months ended

September 30, 2008, on an adjusted cash basis, are dilutive shares

consisting of 2,349,000 common stock equivalent shares from the

potential exercise of stock options and warrants and potential

dilutive shares consisting of 3,411,000 common stock equivalent

shares from the potential conversion of convertible debt securities.

The net income per dilute
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 16, 2013 A new selection ... from Cole-Parmer is designed to meet the dynamic ... , The new Cole-Parmer® MS-3400 Centrifuges ... the lab. They ensure a powerful and complete ... separation. Their standard four-place swinging buckets hold 50-mL ...
(Date:5/16/2013)... 16, 2013 Kitware , ... today announces new Phase II SBIR funding from ... development of an open-source, high performance computing (HPC) ... framework enables researchers to select only the toolkits ... simulation, computation, or analysis tasks. , Manufacturers ...
(Date:5/16/2013)... May 16, 2013  The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...
(Date:5/16/2013)... May 16, 2013 As the weather warms, ... their favorite Spring looks. While most make a statement with ... many women find the warmer weather mixes makeup and sweat ... with the onset of acne during warmer months, Adult ... acne treatment users the best ways to deter breakouts. ...
Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2
... /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.,(NYSE: ... device,research and development outsourcing company with operations in ... Ge Li, the Company,s Chairman and,Chief Executive Officer, ... Conference on Tuesday, January 13, 2009, at 4:30 ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) today ... W. Duggan & Associates ("RWD") made an unsecured ... the amount of $5,000,000. As of,December 31, ... $12.9 million, including the $5,000,000 in loan proceeds. ...
... Inc. (NASDAQ: VSGN ; TSX:VAS) today provided ... previously announced restructuring plan, Vasogen has been reviewing ... value. This process has included screening, reviewing, and ... Company, a merger or acquisition, and exploring the ...
Cached Biology Technology:WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference 2Pharmacyclics Secures $5.0 Million in Debt Financing 2Pharmacyclics Secures $5.0 Million in Debt Financing 3Vasogen Provides Corporate Update 2Vasogen Provides Corporate Update 3
(Date:5/16/2013)... players and athletes choose to wear the color red ... in Psychological Science , a journal of the ... to do with their testosterone levels. , The new ... University of Sunderland and colleagues, demonstrated that males who ... had higher testosterone levels than other males who chose ...
(Date:5/16/2013)... about 23 million years old give unprecedented insight ... one of the most species-rich groups among the ... Professor Bettina Reichenbacher from the Division of Paleontology ... Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich / ... fossils which they assign to the group of ...
(Date:5/16/2013)... Top neuroscientists from Canada and around the world ... Annual Canadian Neuroscience Meeting will showcase the latest ... system and reveal clues to understanding the disorders ... neuroscience research, and this meeting will showcase the ... the world," says Sam David, President of the ...
Breaking Biology News(10 mins):High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 37th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... Cowman from the Walter and Eliza Hall Institute in ... Royal Society, the UK,s peak academy promoting excellence in ... fellows inducted to the Royal Society in 2011, including ... peer review process on the basis of excellence in ...
... May 2011. The research vessel Polarstern of the Alfred ... Helmholtz Association will arrive back at its homeport of ... Nearly 200 researchers from institutes in 15 countries took ... measurements showing that warming of the water in the ...
... To David Cleveland, a professor of environmental studies at ... would be a great example of what many are advocating ... network a local food system. Santa Barbara County ... United States in value of agricultural products, with 80 percent ...
Cached Biology News:Top Australian malaria researcher elected Fellow of the Royal Society 2Top Australian malaria researcher elected Fellow of the Royal Society 3Research ship Polarstern returns from Antartica 2Research ship Polarstern returns from Antartica 3UCSB localizing fruit, vegetable consumption doesn't solve environmental, health issues 2UCSB localizing fruit, vegetable consumption doesn't solve environmental, health issues 3
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Form: Concentrated Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Form: Ready to use Applications: Western Blot, ELISA...
Biology Products: